These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7947096)

  • 1. Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.
    Englefield P; Foulkes WD; Campbell IG
    Br J Cancer; 1994 Nov; 70(5):905-7. PubMed ID: 7947096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.
    Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U
    Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
    Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
    Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene.
    Watkins D; Ruttledge MH; Sarrazin J; Rangaratnam S; Poisson M; Delattre JY; Rouleau GA
    Cancer Genet Cytogenet; 1996 Nov; 92(1):73-8. PubMed ID: 8956876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
    De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L
    Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation.
    Cheng JQ; Lee WC; Klein MA; Cheng GZ; Jhanwar SC; Testa JR
    Genes Chromosomes Cancer; 1999 Mar; 24(3):238-42. PubMed ID: 10451704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
    Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
    Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
    Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
    Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.
    Leone PE; Bello MJ; Mendiola M; Kusak ME; De Campos JM; Vaquero J; Sarasa JL; Pestana A; Rey JA
    Int J Mol Med; 1998 May; 1(5):889-92. PubMed ID: 9852312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
    Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
    J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor.
    Fukasawa T; Chong JM; Sakurai S; Koshiishi N; Ikeno R; Tanaka A; Matsumoto Y; Hayashi Y; Koike M; Fukayama M
    Jpn J Cancer Res; 2000 Dec; 91(12):1241-9. PubMed ID: 11123422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.
    Wellenreuther R; Kraus JA; Lenartz D; Menon AG; Schramm J; Louis DN; Ramesh V; Gusella JF; Wiestler OD; von Deimling A
    Am J Pathol; 1995 Apr; 146(4):827-32. PubMed ID: 7717450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
    Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
    Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas.
    Schipper H; Papp T; Johnen G; Pemsel H; Bastrop R; Müller KM; Wiethege T; Jaworska M; Krismann M; Schiffmann D; Rahman Q
    Int J Oncol; 2003 May; 22(5):1009-17. PubMed ID: 12684666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.
    Tavassoli M; Steingrimsdottir H; Pierce E; Jiang X; Alagoz M; Farzaneh F; Campbell IG
    Br J Cancer; 1996 Jul; 74(1):115-9. PubMed ID: 8679443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer.
    Liu MC; Choong DY; Hooi CS; Williams LH; Campbell IG
    Cancer Lett; 2007 Mar; 247(1):91-7. PubMed ID: 16644110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p300 gene alterations in colorectal and gastric carcinomas.
    Muraoka M; Konishi M; Kikuchi-Yanoshita R; Tanaka K; Shitara N; Chong JM; Iwama T; Miyaki M
    Oncogene; 1996 Apr; 12(7):1565-9. PubMed ID: 8622873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas.
    Hoang-Xuan K; Merel P; Vega F; Hugot JP; Cornu P; Delattre JY; Poisson M; Thomas G; Delattre O
    Int J Cancer; 1995 Feb; 60(4):478-81. PubMed ID: 7829260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.